Manufacture of basic pharmaceutical products
NABAS AS
Revenue 2024
NOK 13.4m
Operating profit
NOK 4.0m
Equity
NOK 18.1m
Incorporated
1996
Employees
8
Share capital
NOK 111,000
Key figures · 2024
Current ratio
9.33
Equity ratio
89.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 30.0% | |
| Net margin (%%) | 33.3% | |
| Return on assets (%%) | 19.8% | |
| Likviditet | ||
| Current ratio | 9.33 | |
| Working capital | 17.9m | |
| Soliditet | ||
| Equity ratio (%%) | 89.4% | |
| Debt-to-equity ratio | 0.12 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.